We design tailored antibody panels specifically for your lead candidates, including complex bispecific and multi-specific formats to maximize target detection and binding.
Cancer Stem Cell Immune Checkpoint Expression Testing Service
Creative Biolabs provides an end-to-end testing platform dedicated to the molecular characterization of cancer stem cell (CSC) immune evasion. We provide precise quantification of checkpoint expression, spatial mapping of the stem cell niche, and functional analysis of how CSCs manipulate the surrounding microenvironment. By utilizing our service, clients gain actionable biological insights that allow for the identification of novel drug targets, the optimization of antibody binding affinities, and the discovery of synergistic combination therapies. Our goal is to provide the high-resolution data necessary to ensure your lead compounds effectively eliminate the most resilient cells within a tumor population.
Introduction What We Can Offer How We Can Help Why Creative Biolabs Customer Reviews FAQs Related Services Contact Us
Molecular Profiling of Cancer Stem Cell Immune Checkpoints
The failure of many experimental immunotherapies is often attributed to the "immune-privileged" nature of CSCs. Literature indicates that CSCs utilize a complex network of DNA Damage Response (DDR) signaling and metabolic pathways (ALDH) to upregulate checkpoints like PD-L1, CD47, and HLA-G. Creative Biolabs' service provides the high-precision profiling necessary to unmask these cells in research models, enabling the development of therapies designed to eradicate the tumor at its source.
Request a Consultation →
Fig.1 Key hallmarks of CSCs and their crosstalk with immune checkpoints. 1
What We Can Offer
Customized Panel Design
One-Stop Analytical Service
Our team delivers an integrated workflow from primary tumor tissue dissociation and CSC enrichment through to high-dimensional spectral profiling and deep data analysis.
Large-Scale Processing Capability
We offer high-throughput processing capable of handling extensive research cohorts with over 100,000 cells analyzed per sample to ensure statistical power and reliability.
Well-Established Quality System
We utilize rigorous Quality-by-Design and process analytical techniques to ensure reproducible data for high-impact research publications and early-stage discovery filings.
How Creative Biolabs Can Assist Your Project
Highlights
Expert Leadership in Biology
Partnering with Creative Biolabs provides access to deep expertise in stem cell biology for identifying hidden cellular niches in cold tumor models.
Literature-Driven Panel Optimization
We utilize peer-reviewed oncology data to refine our screening panels, ensuring precise targeting of critical regulatory axes and various innate checkpoints.
Advanced Sex-Stratified Profiling
Our unique profiling approach accounts for biological dimorphism, ensuring that your drug discovery process captures essential differences in male and female models.
Strategic Preclinical De-risking
We provide high-resolution insights into resistant cell populations to help researchers identify potential lead optimization issues before moving to advanced studies.
Experience the advantage firsthand by integrating our specialized CSC insights into your next research phase.
Customer Reviews
-
Enhanced Target Identification
Using Creative Biolabs' CSC testing in our lung cancer research has improved our ability to identify why certain models showed resistance to PD-1 inhibitors. The intracellular reservoir data was a notable addition to our research project. - Dr. J***n. S. -
Breakthrough in Combination Strategy
Using the reciprocal crosstalk assay in our research has facilitated our understanding of how CSCs manipulate immune cells. We discovered a synergy between our lead and a DNA-repair inhibitor in our cell models. - Prof. M***o. R.
FAQs
How do you ensure the markers used are specific to my research model?
We customize every panel based on established literature for your specific tumor type. We combine classic markers like CD133 with functional assays to ensure the highest purity of the CSC population in your samples.
Can this service help identify why my current lead is failing in research models?
Yes. We often find that compounds effective against bulk cells fail to reach the CSC "sanctuary." Our spatial analysis and adaptive resistance profiling can pinpoint exactly how CSCs are evading your molecule in vitro and in vivo.
Related Services
Circulating Cancer Stem Cell Detection Service
We offer specialized detection of metastatic precursor cells in fluid samples to track systemic tumor dissemination throughout preclinical research phases.
Learn More →Cancer Stem Cell Exosome Biomarker Detection Service
We analyze CSC-derived vesicles to identify unique protein and RNA signatures that facilitate immune evasion and niche reprogramming within preclinical research environments.
Learn More →How to Contact Us
Creative Biolabs is your premier partner for cancer stem cell immune checkpoint expression testing. From deep phenotypic profiling and intracellular reservoir analysis to signaling axis mapping and sex-stratified research data, we provide the scientific clarity required to transform drug discovery pipelines.
For detailed project discussions, pricing, and technical consultations, please reach out to our team.
Reference
- Hussein, Ola J et al. "The role of immune checkpoints in modulating cancer stem cells anti-tumor immune responses: implications and perspectives in cancer therapy." Journal of experimental & clinical cancer research : CR vol. 44,1 305. 13 Nov. 2025. Distributed under an Open Access license CC BY 4.0, without modification. https://doi.org/10.1186/s13046-025-03514-4
Download our brochureLoading case studies...
Online Inquiry